company

About Us

Rophibio is a biopharmaceutical company that is dedicated to enhancing the lives of patients through the development of high-quality biosimilars and new medicines.

좌우스크롤 이미지After clicking on the screen, please scroll down at the bottom or move the screen left or right.

  • Antibody
    Therapeutics

  • Protein
    Therapeutics

Biosimilar Drug Development Utilizing Rophibio's Cell Line Development Platform

Our Business Areas

 

Biosimilars

Monoclonal antibodies
Fusion proteins

Biopharmaceuticals

Protein/antibody drugs
Gene/cell therapy

Cell Line
Development

Monoclonal cell line screening
Early process development
Analytical testing
Research cell banking